Stories
MedPlus CEO Pauses Integrated Diagnostics, Shifts to Smaller Standalone Labs
C
CNBC TV18•21-09-2026, 12:53
MedPlus CEO Pauses Integrated Diagnostics, Shifts to Smaller Standalone Labs
- •MedPlus CEO Gangadi Madhukar Reddy has paused plans for an integrated radiology and biochemistry lab network due to a shortfall in subscribers for the Hyderabad diagnostics business.
- •The company will now open smaller, standalone diagnostic labs, with each new lab costing approximately ₹5 crore to ₹6 crore, starting with Bengaluru and Chennai.
- •MedPlus remains on track to open 800 stores by year-end and expects a recovery in this quarter's earnings.
- •Reddy did not rule out a potential sale of the diagnostics business, stating the company considers all available options.
- •Plans for concierge and wellness services, as well as a food park unit for cold-pressed oil, have also been put on hold.
Key Questions Answered
MedPlus decided to pause its integrated radiology and biochemistry lab network plan due to a shortfall in subscribers for the Hyderabad diagnostics business.
Instead of the integrated network, MedPlus plans to open standalone smaller labs in Bengaluru and Chennai, with each new lab costing about ₹5 crore to ₹6 crore.
MedPlus CEO Gangadi Madhukar Reddy did not rule out the possibility of selling the diagnostics business, stating that the company always evaluates options on the table.
